BLU-782 is effective in preventing heterotopic ossification after fibular osteotomy. Credit: Science Translational Medicine (2024). DOI: 10.1126/scitranslmed.abp8334 Several teams of medical researchers are currently testing new therapies for slowing or stopping the excess or runaway bone growth associated with fibrodysplasia ossificans progressive (FOP)—a rare bone disease. The team behind one such effort, with members from Blueprint Medicines […]
